Clancy, Noah
Aslam, Tariq
Cackett, Peter
Article History
Received: 28 February 2022
Accepted: 19 May 2022
First Online: 2 June 2022
Declarations
:
: Ethical approval was obtained from the local health board (NHS Lothian) quality improvement and audit committee.
: Not applicable.
: The authors declare that they have no competing interests that might be perceived to influence the results and/or discussion reported in this paper. For competing interests as per BMC: PC—travel grant recipient from Bayer, Novartis and Allergan and Honoraria recipient from Bayer, Novartis, Allergan and Roche. TA—speaker fees and consultant for Bayer, Novartis, Roche, Heidelberg, Topcon, Canon and Thea Pharmaceuticals. None of the above would have influenced the results and/or discussion in any manner.